Local biomed sees future in hi-tech
Mar. 30, 2014
The future of Israel’s biomed and life-sciences industry lies in the hi-tech world, according to industry leaders.
“As you look at the mega-trends and the things that influence us, one of the most notable ones is the future of digital health care,” Yoav Chelouche, managing partner at Aviv Venture Capital, told The Jerusalem Post in a recent interview.
More than 90 Israeli companies are involved in some way in the issues of digital health, he said, including wearable sensors, remote monitors for patients with chronic illnesses, medication- adherence software and 3-D printing of custom-made prosthetics.
According to Benny Zeevi, managing general partner at DFJ TelAviv Venture Partners, the vast majority of Fortune 150 companies are involved in health care in some way, whether from the software angle (IBM, SAP, Oracle), creating special chips for health devices (Qualcomm, Intel) or offering retail products (Walmart, Best Buy). Even mobile operators such as Orange, Vodafone and AT&T are getting into the game.
“All of them see a huge potential in bringing health care to the consumer through hi-tech,” Zeevi told the Post.
For the full Jerusalem Post interview with both IATI Co-chairmen click here.